Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

5 things that have influenced pharmaceutical digital marketing expansion
Med City News
Wednesday, August 15, 2012 - 10:13pm
tags:
social media, digital pharma, digital marketing
Analyst: The Better Desktop DNA Sequencer May Be Losing The Marketing War
Forbes
Wednesday, August 15, 2012 - 11:40am
tags:
DNA sequencing, Life Technologies, Illumina
Arena jumps 12% amid takeover speculation
Marketwatch
Wednesday, August 15, 2012 - 11:23am
tags:
Arena Pharmaceutical, M&A
Icahn appears to win one board seat at Forest Labs
Yahoo/Reuters
Wednesday, August 15, 2012 - 11:20am
tags:
Carl Icahn, Forest Labs
Docs see twice as many iPad-carrying reps
Fierce Pharma
Wednesday, August 15, 2012 - 11:17am
tags:
iPad, drug reps, physicians
New pharma trial: Pfizer, GSK, J&J test 1-page drug information sheets
Fierce Pharma
Wednesday, August 15, 2012 - 11:16am
tags:
Pfizer, JNJ, GSK, drug information sheets
Eisai CEO Sees 'Huge' Medical Need for New Diet Drug
WSJ Online
Wednesday, August 15, 2012 - 11:15am
tags:
Eisai, obesity, Haruo Naito, Belviq, Arena Pharmaceuticals
BI posts strong sales but warns of tough times ahead
Pharma Times, UK
Wednesday, August 15, 2012 - 11:13am
tags:
Boehringer Ingelheim
GSK sells Australian drugs to Aspen for $270 mln
Yahoo/Reuters
Wednesday, August 15, 2012 - 11:12am
tags:
GSK, Aspen, South Africa
Watson sues FDA on generic diabetes drug ruling
Yahoo/Reuters
Wednesday, August 15, 2012 - 11:10am
tags:
FDA, generics, Watson Pharmaceuticals, diabetes, Actos, Takeda
Democrats Caution Gilead Over Quad Pricing
Pharmalot
Wednesday, August 15, 2012 - 11:09am
tags:
drug pricing, Gilead, HIV, Quad
4 Undervalued Healthcare Stocks With Strong Inventory Trends
Seeking Alpha
Wednesday, August 15, 2012 - 11:08am
tags:
Anika, China Biologic, USANA Health Sciences
Spectrum launches FUSILEV marketing campaign
Yahoo/Fly on the Wall
Wednesday, August 15, 2012 - 11:03am
tags:
Fusilev, Spectrum Pharmaceuticals
Bristol-Myers launches patient management programs for Sprycel patients
The Fly on the Wall
Wednesday, August 15, 2012 - 11:00am
tags:
Sprycel, leukemia, Bristol-Myers Squibb
Horizon Pharma's Unsustainable Business Model
Seeking Alpha
Wednesday, August 15, 2012 - 10:59am
tags:
Horizon Pharma
Teva: Lower PE And Faster EPS Growth Than The Major Drug Makers
Seeking Alpha
Wednesday, August 15, 2012 - 10:58am
tags:
Teva Pharmaceuticals, Merck, JNJ, Pfizer, Bristol-Myers Squibb
Alnylam, AstraZeneca form strategic alliance for microRNA
Yahoo/Fly on the Wall
Wednesday, August 15, 2012 - 10:54am
tags:
microRNA, Alnylam, AstraZeneca, Regulus
Forest Labs vs Icahn Approaches Showdown Tomorrow
WSJ Online
Tuesday, August 14, 2012 - 4:03pm
tags:
Forest Labs, Carl Icahn
Will New RA Therapies Cause a Paradigm Shift?
Pharma Live
Tuesday, August 14, 2012 - 2:25pm
tags:
TNF blockers, rheumatoid arthritis, Humira, Abbott Laboratories, Pfizer, JAK inhibitors, tofacitinib, Amgen, Embrel, Remicade, JNJ
With Cytori Therapeutics, The Waiting Is The Hardest Part
Seeking Alpha
Tuesday, August 14, 2012 - 11:09am
tags:
Cytori

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.